IDB Holland bv, your partner in nuclear medicineLutetium 177, radiopharmaceuticals and sources for nuclear medicine.
It is with deep and profound sadness that we learned that our founder, inspiratior and friend has passed away suddenly. The passing of Jan leaves an indescribable emptiness. With heart and soul, he has worked to bring our company where it is today. Especially the fact that now, so soon after his retirement, he may no longer enjoy his well deserved rest leaves us intensely sad. We are convinced however, that his spirit will bring us even further. Jan, thank you for who you were! >> read more
7 January 2016, Saint-Genis-Pouilly, France – Advanced Accelerator Applications S.A. (“AAA” or “the Company”) (Nasdaq: AAAP), an international specialist in Molecular Nuclear Medicine (“MNM”), announced today that it has acquired 100% of the shares of the IDB Group. The IDB Group includes IDB Holland bv, IDB Radiopharmacy bv and Beheermaatschappij Welde bv and is a leading manufacturer of Lutetium 177 (Lu-177). IDB produces, markets and sells Lu-177 under the brand name LuMark®, and has established this product as the leading brand of Lutetium 177 worldwide. LuMark® is the only Lu-177 product to have received European Marketing Authorization. >> read more
IDB Holland BV is a leading manufacturer of Lutetium 177 (Lu 177). Under the brand name of LuMark Lutetium 177 is being produced on a weekly basis. With daily shipments to destinations all over the world LuMark Lu 177 has already established itself as the leading brand of Lutetium 177. >> read more